Xavier Leray

Rossella Conti

Yan Li

Cécile Debacker

Florence Castelli

François Fenaille

Anselm A Zdebik

Michael Pusch

Bruno Gasnier
email: bruno.gasnier@u-paris.fr

Arginine-selective modulation of the lysosomal transporter PQLC2 through a gate-tuning mechanism

Keywords: transporter, lysosome, amino acid, gating, nutrient signaling

ou non, émanant des établissements d'enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.

INTRODUCTION

Lysosomes maintain cells and tissues by degrading unwanted macromolecules, aggregates, organelles, and cell debris through endocytosis, phagocytosis and autophagy. The building blocks released by lysosomal hydrolysis are exported to the cytosol by membrane transporters for reuse in biosynthetic pathways. A transcriptional feedback loop regulates lysosomal biogenesis and autophagy genes to adapt this degradative pathway to cellular needs [START_REF] Ballabio | Lysosomes as dynamic regulators of cell and organismal homeostasis[END_REF]. Lysosomal degradation also provides a route to acquire nutrients from extracellular macromolecules when free nutrients are scarce in the environment [START_REF] Verdon | SNAT7 is the primary lysosomal glutamine exporter required for extracellular protein-dependent growth of cancer cells[END_REF][START_REF] Wyant | mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient Article mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient[END_REF]. Besides these catabolic roles, lysosomes also constitute signaling hubs which integrate environmental and intracellular cues to control protein synthesis, anabolic pathways and autophagy through the mechanistic target of rapamycin complex 1 (mTORC1) pathway. Intracellular amino acids activate Rag GTPases to recruit mTORC1 to lysosomes, where it is activated by the Rheb GTPase in response to nucleotide levels, oxygen, energy status and growth factors [START_REF] Condon | Nutrient regulation of mTORC1 at a glance[END_REF][START_REF] Lawrence | The lysosome as a cellular centre for signalling, metabolism and quality control[END_REF]. Amino acid sensing by mTORC1 involves cytosolic and lysosomal membrane proteins which recognize specific amino acids or their metabolites. Leucine, a key activator of mTORC1, is sensed in the cytosol by Sestrin2 with micromolar affinity (EC50 ≈ 20 µM). Upon leucine binding, Sestrin2 dissociates from, and activates, GATOR2, a positive regulator of mTORC1 [START_REF] Wolfson | The Dawn of the Age of Amino Acid Sensors for the mTORC1 Pathway[END_REF]. Methionine is sensed through its metabolite, Sadenosylmethionine by SAMTOR, another cytosolic sensor. In its absence, SAMTOR activates GATOR1 to inhibit mTORC1. S-adenosylmethionine binding disrupts the interaction of SAMTOR with GATOR1 and its lysosomal scaffold KICSTOR, thus suppressing the inhibition of mTORC1 [START_REF] Condon | Nutrient regulation of mTORC1 at a glance[END_REF]. Arginine (Arg), another key activator of mTORC1, is sensed in the cytosol, but also in the lysosomal lumen, by distinct sensors. In the cytosol, CASTOR1 homodimers and CASTOR1-CASTOR2 heterodimers bind Arg with micromolar affinity (EC50 ≈ 25 µM) to dissociate from, and activate, GATOR2 [START_REF] Wolfson | The Dawn of the Age of Amino Acid Sensors for the mTORC1 Pathway[END_REF]. Arg is also sensed by the lysosomal membrane protein SNAT9, also known as SLC38A9, which has a dual function: it is a lysosomal exporter of essential amino acids gated by luminal Arg [START_REF] Wyant | mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient Article mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient[END_REF] and it acts as an Arg and cholesterol sensor to activate RagA/B-C/D heterodimers, and hence mTORC1, by stimulating the GTPase activity of the folliculin-FNIP2 complex toward RagC [START_REF] Rebsamen | SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1[END_REF][START_REF] Castellano | Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex[END_REF][START_REF] Wang | Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1[END_REF][START_REF] Jung | Amino Acid-Dependent mTORC1 Regulation by the Lysosomal Membrane Protein SLC38A9[END_REF][START_REF] Fromm | Structural mechanism for amino acid-dependent Rag GTPase nucleotide state switching by SLC38A9[END_REF]. Arg stimulates both SNAT9 activities in the high micromolar range (EC50 = 100-200 µM). As its central cavity is able to bind Arg in the cytosol-facing conformation [START_REF] Lei | Crystal structure of arginine-bound lysosomal transporter SLC38A9 in the cytosol-open state[END_REF], SNAT9 might sense both luminal and cytosolic Arg to activate mTORC1. SNAT9 has a very low transport activity for Arg [START_REF] Wyant | mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient Article mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient[END_REF]. The primary lysosomal transporter for Arg, along with other cationic amino acids (CAA), has been identified as the PQ-loop repeat containing protein 2 (PQLC2; pronounced 'picklock two' for convenience) [START_REF] Liu | LAAT-1 Is the Lysosomal Lysine/Arginine Transporter That Maintains Amino Acid Homeostasis[END_REF][START_REF] Jézégou | Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy[END_REF], encoded by the SLC66A1 gene [START_REF] Kandasamy | Amino acid transporters revisited: New views in health and disease[END_REF]. PQLC2 belongs to the PQ-loop protein family (Pfam #PF04193) characterized by the presence of 7 transmembrane helices and a duplicated motif with a highly-conserved proline-glutamine dipeptide. Its founding member, cystinosin, is a H + -coupled lysosomal cystine transporter defective in human cystinosis [START_REF] Town | A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis[END_REF][START_REF] Ruivo | Mechanism of proton/substrate coupling in the heptahelical lysosomal transporter cystinosin[END_REF][START_REF] Huizing | Inherited disorders of lysosomal membrane transporters[END_REF]. These amino acid transporters are distantly related to the SWEET and SemiSWEET sugar transporters, the mitochondrial pyruvate carrier and the KDEL receptor [START_REF] Feng | Evolution of Transporters: The Relationship of SWEETs, PQ-loop, and Transporters[END_REF][START_REF] Newstead | Molecular basis for KDEL-mediated retrieval of escaped ER-resident proteins -SWEET talking the COPs[END_REF].

As SNAT9, PQLC2 has a dual role in amino acid recycling and amino acid signaling at the lysosomal membrane. It selectively exports Arg, Lys and His from the lysosomal lumen [START_REF] Liu | LAAT-1 Is the Lysosomal Lysine/Arginine Transporter That Maintains Amino Acid Homeostasis[END_REF][START_REF] Jézégou | Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy[END_REF]. This transport activity is essential for the cysteamine therapy of cystinosis because it provides a salvage pathway to deplete lysosomal cystine by exporting a lysine-like cysteamine-cysteine mixed disulfide from the lysosomal lumen [START_REF] Liu | LAAT-1 Is the Lysosomal Lysine/Arginine Transporter That Maintains Amino Acid Homeostasis[END_REF][START_REF] Jézégou | Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy[END_REF]. On the other hand, PQLC2 acts as a lysosomal receptor that recruits the C9orf72-SMCR8-WDR41 (CSW) complex to lysosomes under CAA starvation [START_REF] Amick | PQLC2 recruits the C9orf72 complex to lysosomes in response to cationic amino acid starvation[END_REF]. In C. elegans, the PQLC2 orthologue LAAT-1 decreases sensitivity to endoplasmic reticulum stress. This role apparently involves its amino acid transport activity rather than amino acid sensing because CAA supplementation rescues the phenotype of laat-1 mutants [START_REF] Higuchi-Sanabria | Lysosomal recycling of amino acids affects ER quality control[END_REF].

The CSW complex is involved in autophagy, lysosome biogenesis, phagosome maturation, actin dynamics and downregulation of Toll-like receptors [START_REF] Lawrence | The lysosome as a cellular centre for signalling, metabolism and quality control[END_REF][START_REF] O'rourke | C9orf72 is required for proper macrophage and microglial function in mice[END_REF][START_REF] Sivadasan | C9ORF72 interaction with cofilin modulates actin dynamics in motor neurons[END_REF][START_REF] Mcalpine | Excessive endosomal TLR signaling causes inflammatory disease in mice with defective SMCR8-WDR41-C9ORF72 complex function[END_REF][START_REF] Amick | C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease[END_REF] and its dysfunction is implicated in frontotemporal degeneration and amyotrophic lateral sclerosis [START_REF] Lawrence | The lysosome as a cellular centre for signalling, metabolism and quality control[END_REF][START_REF] Amick | C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease[END_REF]. Recent studies showed that it acts as a GTPaseactivating protein towards a specific set of small GTPases, including Arf1, Arf5, Arf6, Rab8a and Rab11a [START_REF] Tang | Cryo-EM structure of C9ORF72-SMCR8-WDR41 reveals the role as a GAP for Rab8a and Rab11a[END_REF][START_REF] Su | Structure of the C9orf72 ARF GAP complex that is haploinsufficient in ALS and FTD[END_REF] and that it associates with lysosomes under amino acid starvation through an interaction between its WDR41 subunit and PQLC2 [START_REF] Amick | PQLC2 recruits the C9orf72 complex to lysosomes in response to cationic amino acid starvation[END_REF].

In this study, we characterized the ion and voltage dependence of PQLC2 transport activity using electrophysiology. In the course of this study, we discovered a specific modulation of the PQLC2 current by Arg, but not other substrates (Lys, His). Investigation of the underlying mechanism using electrophysiology and kinetic modeling identified a specific effect of Arg on PQLC2 gating as the most plausible explanation. This mechanism suggests in turn a hypothetical model for the amino acid signaling function of PQLC2.

RESULTS

PQLC2 is a cationic amino acid uniporter

To examine the ion-coupling properties of PQLC2, we first measured its charge/substrate ratio by applying tritiated arginine ([ 3 H]Arg) to voltage-clamped oocytes expressing PQLC2-LL290/291AA-EGFP at the plasma membrane (hereafter referred to as PQLC2 oocytes). Experiments were done at pH 5.0 to mimic the acidic lumen of the lysosome and to activate PQLC2 [START_REF] Jézégou | Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy[END_REF]. The time integral of the evoked current was proportional to the amount of accumulated [ 3 H]Arg (Fig. 1A), with a slope of 0.94 positive elementary charge per cationic Arg molecule (R 2 = 0.958, n = 18 oocytes). Thus, if PQLC2 transports inorganic ions together with Arg, their contribution to the charge flux should compensate each other.

We next asked whether PQLC2 is coupled to protons like many lysosomal transporters [START_REF] Verdon | SNAT7 is the primary lysosomal glutamine exporter required for extracellular protein-dependent growth of cancer cells[END_REF][START_REF] Ruivo | Mechanism of proton/substrate coupling in the heptahelical lysosomal transporter cystinosin[END_REF]29). The internal pH (pHin) of PQLC2 oocytes was monitored under voltage clamp with a pH-sensitive fluorescent probe (BCECF) or a H + -selective electrode. Applications of Arg or Lys at pHout 6.0 or 5.0 induced robust currents but did not detectably alter pHin. In contrast, application of His acidified PQLC2 oocytes (Fig. 1B andS1A,B,D,E). The acidification rate was proportional to the His current above a threshold of 131 ± 26 nA (n = 5; Fig. 1C andS1D,F). As His has a lower side chain pKa (6.0) than Lys and Arg (10.5 and 12.5, respectively), this cytosolic acidification must reflect the release of protons from cationic His molecules imported by PQLC2 (Fig. 1D). In agreement with this model, canavanine, another PQLC2 substrate [START_REF] Jézégou | Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy[END_REF] with a low side-chain pKa (7.0; oxyguanidinium group) acidified PQLC2 oocytes (SI Appendix, Fig. S1 C). Therefore, PQLC2 is not coupled to protons. Its activation at low luminal (extracellular) pH ( 14) reflects a kinetic, but not a thermodynamic, effect.

Finally, we examined the possibility that ions other than protons drive PQLC2 transport. As we had noticed that PQLC2 oocytes substantially accumulate CAAs during current measurements (see below), we took advantage of this effect to measure PQLC2 reversal potentials (Vrev). PQLC2 oocytes were perfused for 5 to 15 min with 20 mM Lys or Arg to increase their internal CAA concentration ([CAA]in) and immediately afterwards were subjected to voltage jumps at varying external CAA concentrations ([CAA]out) to determine Vrev (Fig. 2A,B). A stable [CAA]in level was maintained throughout the experiment (Fig. 2C, purple dot). Vrev values varied linearly with log([Lys]out) and log([Arg]out) with mean slopes of 52 ± 2 (± SEM; n = 6 oocytes) and 57 ± 3 mV/decade (n = 8), respectively (Fig. 2C,D). The PQLC2 cycle is thus thermodynamically coupled with the transfer of one positive elementary charge per CAA molecule. To test whether PQLC2 is coupled to inorganic ions, we changed [Na + ]out, [K + ]out, [Cl -]out and pHout by one to two order of magnitudes and examined the impact on Vrev. None of these conditions altered Vrev (Fig. 2E), excluding these ions from the transport cycle.

Altogether, these data indicate that PQLC2 is a CAA uniporter or a CAA channel. As PQLC2 contains conserved PQ motifs which are critical for alternating-access transitions in related SemiSWEET transporters [START_REF] Latorraca | Mechanism of Substrate Translocation in an Alternating Access Transporter[END_REF], a channel mechanism is unlikely.

Luminal Arg inwardly rectifies the PQLC2 current

We next examined the voltage dependence of the transport current for various substrates. Intriguingly, first studies of Arg transport yielded inconsistent I-V curves, with a large, variable, paradoxical inward current at positive potentials (see below) in apparent contradiction with the uniport mechanism. This paradox could be solved when I-V curve measurements were initiated before any exposure of PQLC2 oocytes to exogenous CAAs ('naive' oocytes), allowing to define a background current subtraction procedure that is not influenced by substrate accumulated inside the oocytes (see below).

Representative current traces of a naive PQLC2 oocyte perfused twice with 20 mM Lys are shown in Fig. 3A,C,F. The first application evoked an inward current at negative potential, as expected. Surprisingly, an outward current was also induced at positive potential. This response could be assigned to the efflux of Lysin accumulated during Lys perfusion based on the following evidence: (i) the outward current persisted, and increased, after washing out Lys from the bath (Fig. 3A,F); (ii) it correlated with the PQLC2 expression level (SI Appendix, Fig. S2C); (iii) amino acid measurements confirmed the rise of [Lys]in well above its endogenous level after a single Lys application (Fig. 3E). When Lys was applied again, the outward current seemed to vanish when we used a classical subtraction to extract the PQLC2 current (4-3 subtraction in Fig. 3A,C). However, this procedure is inappropriate after the first application because the background current recorded in wash buffer now comprises a Lysin-evoked PQLC2 component. To isolate the actual PQLC2 current, we defined a novel subtraction procedure where the background current recorded in the initial naive state ([Lys]in at minimal, endogenous level) is subtracted to all subsequent applications (4-1 subtraction in Fig. 3A,C). Recordings analyzed with this procedure yielded consistent I-V curves, with a leftward shift on the second application reflecting the increase in [Lys]in (Fig. 3C, right graph; SI Appendix, Fig. S2D). The Lys I-V curves showed an inward rectification consistent with the lower value of [Lys]in (Fig. 2C) relative to [Lys]out in these experiments (see patch-clamp experiments below for the virtual absence of rectification of the Lys-evoked current when [Lys]in = [Lys]out).

We next used this approach to characterize the Arg current. PQLC2 oocytes substantially accumulate Arg like Lys since an outward current correlating with the PQLC2 expression level is observed after washing out Arg from the bath (Fig. 3B,G; SI Appendix, Fig. S2C). However, in contrast with Lys, this outward current is suppressed during Arg application (compare 3-1 and 4-1 subtractions in Fig. 3A,B; see also raw traces in SI Appendix, Fig. S2A). In other terms, extracellular/luminal Arg strongly reduces electrogenic PQLC2 transport from the cytosol to the extracellular/luminal side, i.e. Arg effectively trans-inhibits the uniport activity. In the next Arg application, this effect creates a subtraction artefact with the (improper) classical procedure (Fig. 3D, double arrow). The correct subtraction procedure avoids this artefact and yields consistent inwardly rectifying I-V curves, with a leftward shift upon successive applications reflecting the increase in Argin (Fig. 3G andS2D).

The Lys and Arg currents of PQLC2 differ by their degree of inward rectification: the rectification becomes so strong with Arg that no outward current can be observed in the potential range analyzed. Successive applications of Lys and Arg showed that this effect selectively depends on Argout, regardless of the amino acid carrying the outward current (Fig. 3H andS2B).

To determine the concentration dependence of this effect, we loaded PQLC2 oocytes with high levels of Lys or Arg (to minimize subsequent changes in [Lys]in or [Arg]in) and characterized the PQLC2 I-V curves at varying [Lys]out or [Arg]out, respectively. SI Appendix, Fig. S3 shows the dependence of PQLC2 currents on [CAA]out at -80 and +80 mV. The inward current recorded at -80 mV followed Michaelis-Menten kinetics (SI Appendix, Fig. S3A,C) with KM of 7.3 and 1.7 mM for Lysout and Argout, respectively. The outward current recorded at +80 mV decreased linearly in a gradual manner with Lysout. In contrast, it decreased steeply in a hyperbolic manner with [Arg]out with a Ki of 3.2 mM, a value close to the KM for Argout of the inward current (SI Appendix, Fig. S3B,C).

To confirm the inward rectifying effect of Argout and rule out an artefact from the oocyte expression system, we recorded PQLC2 currents in whole-cell patch-clamped HEK293T cells, a configuration allowing direct delivery of internal amino acids by dialysis from the micropipette solution. Application at pHout 5.0 of 20 mM CAAout to cells expressing PQLC2-LL290/291AA-EGFP at the plasma membrane ('PQLC2 cells') induced a robust inward current, which was not detected in mock cells (Fig. 3I andS2E,F). We applied voltage ramps to characterize the voltage dependence of this current. In the absence of internal amino acid (pipette filled with NMDG buffer), application of 20 mM Lysout, Argout or Hisout yielded nearly superimposable I-V curves. However, when 20 mM Lysin or Argin was included in the pipette, the PQLC2 current evoked by Argout, but not Lysout or Hisout, showed a strong inward rectification (Fig. 3I and S2 E,G), in agreement with the oocyte data.

In conclusion, Argout induces a selective inward rectification of the PQLC2 current, regardless of the amino acid carrying the current, in two expression systems. The concentration dependence of this effect (SI Appendix, Fig. S3B,C) suggests that it involves Arg binding to the extracellular (luminal) side of the transporter.

Cytosolic Arg reduces the PQLC2 current

We next asked whether Arg could also modulate the PQLC2 current from the cytosolic side. We thus measured the PQLC2 current evoked by pulse applications of Lys before and after sustained oocyte loading with either Lys or Arg (Fig. 4A). If the two amino acids interact similarly with PQLC2 on the cytosolic side, the pulse current should be exclusively affected by the shallower CAA gradient across the oocyte membrane after CAA loading. In contrast with this prediction, Arg loading decreased the pulse current to a greater extent than Lys loading (34 ± 1% vs. 78 ± 5% of first-pulse current, respectively; n = 5) although Argin (4.3 ± 0.2 mM) accumulated to lower levels than Lysin (8.1 ± 0.4 mM) (Fig. 4B,C). This Argin-selective reduction also manifested as a steep decrease of the loading current during the first minute of Arg, but not Lys, application (Fig. 4A,arrows). In agreement with the Lys pulse data, tail/peak ratios of 39 ± 4% and 71 ± 5% (n = 5) were measured for the Arg-loading and Lys-loading currents, respectively (Fig. 4D).

Argin thus selectively alters the PQLC2 inward current in a concentration range similar to the inhibition of the outward current by Argout (SI Appendix, Fig. S3B,C). This selective effect of Arg in trans on both sides of PQLC2 suggests that it acts through the translocation pathway rather than through an Arg-selective allosteric site, although we cannot formally exclude the latter possibility.

Arginine trans-inhibits PQLC2

Two potential mechanisms could account for the above data (Fig. 5A). First, the presence of Arg in trans (Argtrans) could shift PQLC2 activity from an electrogenic uniport mode to an electroneutral CAAcis/Argtrans exchange mode undetected by electrophysiology. Alternately, Argtrans could inhibit PQLC2 (uniport + exchange activities). To discriminate between these possibilities, we measured the charge/substrate ratio of PQLC2 in oocytes pre-loaded, or not, with either Lys or Arg. In the first hypothesis, Arg loading should selectively and substantially decrease this ratio whereas in the second hypothesis, the ratio should not be affected (Fig. 5A). The outcome of these experiments is shown in Fig. 5B. While the charge/[ 3 H]Arg ratio of PQLC2 was 1.09 ± 0.04 (n = 6) in naïve PQLC2 oocytes, it decreased to 0.90 ± 0.07 (n = 11) and 0.81 ± 0.04 (n = 9) in Lys-and Arg-loaded oocytes, respectively. The presence of CAA in trans thus shifts 10 to 20% PQLC2 cycles from a uniport mode to an exchange mode. This shift is too small and non-selective to account for the PQLC2 current decrease by Argin (tail/peak ratio = 0.52 ± 0.04, n = 9). Moreover, these effects do not correlate (Fig. 5C). These data ruled out the exchange hypothesis, leaving Arg-induced transinhibition as the most likely mechanism.

To confirm this conclusion, we took advantage of the internal acidification induced by His uptake to measure the overall transport activity (uniport + exchange) of PQLC2 simultaneously with its uniport activity (His current). We thus recorded the intracellular acidification signals evoked by pulse applications of His under voltage clamp before and after oocyte loading with either Lys or Arg. Arg loading decreased the His-evoked acidification to a greater extent (post/pre ratio = 0.36 ± 0.01, n = 7) than Lys loading (ratio = 0.72 ± 0.07, n = 8) (Fig. 5D,E), in agreement with the decrease of the His current (post/pre ratio = 0.39 ± 0.03 and 0.77 ± 0.03 for Arg and Lys, respectively) and of the loading current (tail/peak ratio = 0.53 ± 0.06 and 0.74 ± 0.03 for Arg and Lys, respectively). Altogether, these independent approaches show that Arg trans-inhibits PQLC2.

Gate kinetics modulation by the bound substrate may account for the Arg properties

Trans-inhibition of membrane transporters by non-translocated ligands (blockers) is a well-known phenomenon. However, the trans-inhibition of PQLC2 by Arg is paradoxical since the same compound is both a substrate in cis and an inhibitor in trans. Moreover, among three substrates (Lys, Arg, His) only one displays this dual behavior. To solve this paradox, we modeled the kinetics of PQLC2 and examined whether specific substrate/transporter interactions could induce Arg-like properties.

The kinetics and voltage dependence of PQLC2 was recapitulated in a 6-state uniporter model comprising three conformations (lumen-facing, occluded and cytosol-facing) in apo and loaded states (SI Appendix, Fig. S4A). Uniporter dynamics was explored using a Markov model software. After selecting a set of parameters mimicking the monotonic aspect of PQLC2 I-V curves (SI Appendix, Fig. S4B and Table S1), we studied the influence of substrate-dependent rate constants in a systematic manner. The gating constants in loaded state (𝑘 . , 𝑘 . , 𝑘 . and 𝑘 . ) were set to a low or high value (100 or 1000 s -1 at 0 mV), yielding an array of 16 possibilities (Fig. 6A). One of the two remaining substrate-dependent constants, the dissociation rate on the luminal side (ko.off; see SI Appendix, Fig. S4A), was adjusted across the array to meet the principle of microscopic reversibility (equal clockwise and counterclockwise cycling at 0 mV when [S + ]in = [S + ]out). The dissociation rate from the cytosol-facing site (ki.off) was kept unchanged (KD.in = 1 mM). Apo-state rate constants were also kept unchanged. This systematic survey thus compares 16 substrates interacting differently with the same uniporter.

Next, we simulated the I-V curves of these 16 substrates (20 mM out; 5 mM in) and searched for Arg-like properties based on: (i) the intensity of the outward current at +100 mV and (ii) the effect of internal substrate on the inward current at -50 mV. Results are summarized as a heat map in Fig. 6A. Remarkably, only three substrates (# 10, 11 and 12) mimicked the Arg behavior (low outward and inward currents in the tested conditions) and they share a common feature: a preference of the cytosolic (inner) gate for closure. We selected substrate #11 (S11), with a KD.out of 1 mM (ko.off = 10 -6 s -1 ), as an Arg-mimicking example for further studies. To select a 'regular' (Lys/His-like) substrate, we relied on the fact that external Arg, Lys and His evoke practically superimposable I-V curves in zero-trans condition (Fig. 3I, NMDG-containing cells). Substrate #3 (S3) was the only one matching S11 in this respect (SI Appendix, Fig. S4C), identifying these two substrates as a representative pair of Lys-like and Arg-like PQLC2 substrates. S11 differs from S3 by inducing faster closing of the cytosolic gate and by dissociating more slowly from the lumen-facing site (Fig. 7A).

The two substrates were characterized further in the initial model and a refined model (SI Appendix, Table S1). In zero-trans conditions, they induce similar inward and outward currents (Fig. 6B andS4D, dashed and dashed-dotted lines). However, when the substrate is present on both sides, the S11 I-V curve stands out through its strong inward rectification (Fig. 6B and S4D, solid lines). We quantified uniport and exchange cycles in diverse conditions. Although the presence of S11 in trans induced more exchange than S3, this exchange mode remained limited and did not compensate the large decrease of the uniport mode (Fig. 6C). S11 is thus an efficient trans-inhibitor. In another set of simulations, we assigned a finite volume to the cytosolic compartment and studied the evolution of the loading current during reservoir filling. In agreement with the PQLC2 data, S11, but not S3, loading induced a fast run-down of the loading current although the two substrates initially accumulate at identical rate (Fig. 6D). Our uniporter model thus recapitulates many features of PQLC2.

Analysis of the reservoir filling data showed that the fast run-down induced by S11 tightly correlates with its occupancy of the cytosol-facing site, in contrast with S3 (SI Appendix, Fig. S4E). We performed singletransporter simulations to understand how S11 binding blocks the uniporter. When the cytosolic reservoir is empty, the uniporter quickly cycles in the inward (counterclockwise) direction, as expected (Fig. 6E). When the reservoir fills, S11 binds to the cytosol-facing transporter (IN:S state), triggering the cytosolic gate to close (occluded state, Occ:S) because of the high k S i.op value associated with this substrate. Further 'backward' (clockwise) progression to the lumen-facing state (OUT:S) is however limited by the negative potential. The transporter is thus trapped into a partial equilibrium between the IN, IN:S and Occ:S states (Fig. 6E, shaded areas), leading to trans-inhibition.

It should be noted that this partial equilibrium trap constantly samples substrates from the cytosolic compartment, explaining why cytosolic Arg trans-inhibits the Lys and His currents (Fig. 4 and5D). At highly negative potential, the positive charge of the substrate opposes cytosolic gate closing. The trap is thus overpowered, narrowing the gap between the S3 and S11 currents (Fig. 6B, solid lines). Consistent with this mechanism, the decrease of PQLC2 inward current by Argin is stronger at 0 mV than at -100 mV (Fig. 3H).

Altogether, these simulations suggest that the unique interaction of Arg with PQLC2 may arise from its higher affinity for the lumen-facing substrate site and its modulation of the cytosolic gate (faster closing in Arg-bound than Lys-or His-bound state). The latter feature critically explains the fast run-down of the PQLC2 current by cytosolic Arg.

Potential biological significance of the Arg effect

To assess the biological significance of the Arg/PQLC2 interaction, we examined whether S3 and S11 could differentially alter the uniporter state during nutrient starvation and repletion. Starvation predominantly impacts the cytosolic pool of CAAs (3), resulting in a steeper outward concentration gradient across the lysosomal membrane. We thus made single-transporter simulations with a high (1 mM) or low (0.1 mM) cytosolic concentration to mimic fed and starved conditions, respectively. Voltage was also varied because starvation depolarizes the lysosomal membrane, i.e. the lysosomal lumen becomes less positive [START_REF] Xu | Lysosomal Physiology[END_REF][START_REF] Cang | MTOR regulates lysosomal ATP-sensitive two-pore Na+ channels to adapt to metabolic state[END_REF][START_REF] Saminathan | A DNA-based voltmeter for organelles[END_REF][START_REF] Medina | Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB[END_REF]. Because substrates critically alter cytosolic gating, we focused on the cytosol-facing conformation (fast IN↔IN:S equilibrium in Fig. 7A).

The dwell time of the cytosol-facing conformation in fed and starved conditions is shown in Fig. 7B. In starvation-mimicking conditions, lysosome depolarization increases this dwell time in a similar manner for the two substrates (dashed lines in Fig. 7B). However, upon nutrient repletion, the two substrates have diverging effects: S3 stabilizes the cytosol-facing pauses whereas S11 abrogates these pauses regardless of the membrane potential (solid lines in Fig. 7B). This divergence strengthens when the cytosolic gate has an asymmetrical rather than a symmetrical energy barrier (Fig. 7C). Lysosomal depolarization and S11 repletion thus have antagonistic effects on the propensity of the uniporter to pause in cytosol-facing conformation.

These data suggest the following hypothetical model whereby PQLC2 signals the nutrient status to its interaction partners through opposite effects of the lysosomal potential and Arg levels (Fig. 7D). Recent in situ measurements in live cells showed that lysosomes have a high membrane potential (Vlyso = Vcytosol -Vlumen ≈ -100 mV) in fed state [START_REF] Saminathan | A DNA-based voltmeter for organelles[END_REF], although in some cell types such as RAW 264.7 macrophages lysosomes have a lower hyperpolarization [START_REF] Saminathan | A DNA-based voltmeter for organelles[END_REF][START_REF] Koivusalo | In situ Measurement of the Electrical Potential Across the Lysosomal Membrane Using FRET[END_REF]. Lysosome patch-clamp provided lower or positive values for their membrane potential [START_REF] Xu | Lysosomal Physiology[END_REF][START_REF] Cang | MTOR regulates lysosomal ATP-sensitive two-pore Na+ channels to adapt to metabolic state[END_REF][START_REF] Cao | BK Channels Alleviate Lysosomal Storage Diseases by Providing Positive Feedback Regulation of Lysosomal Ca2+ Release[END_REF][START_REF] Wang | A voltage-dependent K + channel in the lysosome is required for refilling lysosomal Ca 2+ stores[END_REF] but this technique uses artificially enlarged lysosomes and the recorded potential depends on the ionic solution in the micropipette. Upon amino acid starvation, lysosomes depolarize because mTORC1 inactivates, and releases its inhibition of TPC and TPRML1 channels [START_REF] Cang | MTOR regulates lysosomal ATP-sensitive two-pore Na+ channels to adapt to metabolic state[END_REF][START_REF] Saminathan | A DNA-based voltmeter for organelles[END_REF][START_REF] Medina | Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB[END_REF]. Our model predicts that this depolarization should induce pauses of PQLC2 in cytosol-facing conformation, a state which would favor recruitment of the CSW complex. In parallel, mTORC1 inactivation induces autophagy, releasing in the organelle lumen amino acids which are exported by lysosomal transporters. The higher luminal affinity of PQLC2 for Arg would favor Arg export over Lys and His export by remaining CSW-free PQLC2 transporters. The resulting local increase in cytosolic Arg would suppress the cytosol-facing pauses of PQLC2, shifting the CSW complex binding equilibrium towards dissociation even though lysosomes are still depolarized. Finally, when autophagy has replenished amino acids, mTORC1 reactivates and lysosomes return to their hyperpolarized state (Fig. 7D). According to this model, two distinct clues, lysosomal depolarization and cytosolic Arg, would be transduced by PQLC2 to signal the nutrient status to the CSW complex at the surface of lysosomes.

DISCUSSION

In this study, we characterized the energetic and kinetic properties of the lysosomal CAA transporter PQLC2. Three approaches, radioactive uptake under voltage clamp, intracellular pH recording and reversal potential measurements, showed that PQLC2 is uncoupled from lysosomal ion gradients (Fig. 1,2). It thus operates as a uniporter moving CAAs in one direction or the other across the lysosomal membrane depending on the physiological conditions, in contrast with H + -driven lysosomal transporters. The ability of PQLC2 to reverse is determined by lysosomal [CAA] gradients and the lysosomal potential, which in turn depend on the cell type and nutrient status [START_REF] Wyant | mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient Article mTORC1 Activator SLC38A9 Is Required to Efflux Essential Amino Acids from Lysosomes and Use Protein as a Nutrient[END_REF][START_REF] Saminathan | A DNA-based voltmeter for organelles[END_REF]. Arg and Lys fluxes should reverse in an independent manner because PQLC2 has limited exchange activity (Fig. 5B). In the case of His, the lysosomal flux is biased towards export because the low fraction of protonated His in the cytosol limits recognition, and import, by PQLC2. Although thermodynamically uncoupled from the H + gradient, it should be noted that PQLC2 is kinetically controlled by the V-ATPase since its transport activity requires an acidic lumen [START_REF] Jézégou | Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy[END_REF].

PQLC2 is also modulated in a selective, intricate manner by Arg levels. Luminal Arg, but not Lys or His, impairs its outward current (Fig. 3), equivalent to lysosomal import, and, conversely, cytosolic Arg selectively decreases its inward current (Fig. 4), equivalent to lysosomal export. Owing to these effects, Arg-evoked I-V curves have a marked concave-downward shape that contrasts with the Lys and His curves (Fig. 3H,I). Arg and His flux measurements in the oocyte filling paradigm clearly show that these effects are caused by Arg-mediated trans-inhibition rather than a greater propensity of Arg to act as a trans substrate in exchange reactions (Fig. 5). Arg thus interacts with PQLC2 in a unique manner that limits its uphill translocation against the electrochemical gradient.

To examine how such paradoxical substrate-yet-inhibitor properties could arise, we modeled the PQLC2 cycle and systematically explored the influence of substrate-dependent rate constants on the currentvoltage relationship. Strikingly, only a small subset of cases recapitulated the concave-downward aspect of Arg I-V curves and the differences between the Arg and Lys currents could be recapitulated by a pair of substrates, S3 and S11, differing in just two steps of the transport cycle (Fig. 7A). Therefore, a plausible explanation for the unique modulation of PQLC2 by Arg could be the combination of its higher affinity to the lumen-facing site, in agreement with oocyte data (SI Appendix, Fig. S3), with its acceleration of cytosolic gate closing compared to the Lys-bound or His-bound transporter (Fig. 7A). As the guanidinium group of Arg enables a larger number of electrostatic interactions than Lys or His side chains and can interact in three possible directions [START_REF] Musafia | Complex salt bridges in proteins: Statistical analysis of structure and function[END_REF][START_REF] De Freitas | A systematic analysis of atomic protein-ligand interactions in the PDB[END_REF], these features may reflect Arg-specific PQLC2/substrate interactions that stabilize binding to the lumen-facing site and lower the transition state energy of cytosolic gate closing.

In addition to amino acid transport, PQLC2 has been implicated in an amino acid-sensing pathway which recruits the CSW complex to lysosomes when CAAs are scarce [START_REF] Amick | PQLC2 recruits the C9orf72 complex to lysosomes in response to cationic amino acid starvation[END_REF]. To assess whether the above properties could participate in this signaling function, we examined the effect of membrane potential and substrate concentrations on transporter's conformational states in the kinetic model. Because of the differences between S3 and S11, we focused on the cytosol-facing conformation. The dwell time in this conformation is minimal when lysosomes are hyperpolarized, which is their normal state in live cells according to a recent study [START_REF] Saminathan | A DNA-based voltmeter for organelles[END_REF]. During amino acid starvation, lysosomal depolarization increases this dwell time because cytosolic gate closing in apo state (the main exit route at low cytosolic concentration) is less favorable at positive potentials. However, when depolarized lysosomes are exposed to higher cytosolic concentrations, the Arg-like (S11), but not the Lys-like (S3), substrate shortens the cytosol-facing pauses (Fig. 7B,C) owing to its specific effect on the cytosolic gate.

These simulation data lead us to propose a model for the amino-acid sensing function of PQLC2 where the transport recruits the CSW complex in cytosol-facing conformation and where lysosomal depolarization and cytosolic Arg are antagonistic clues sensed by the complex to signal amino acid starvation and repletion, respectively (Fig. 7D). Interestingly, an independent study recently provided homology modeling and biochemical evidence for an interaction of PQLC2 with WDR41 in its cytosol-facing conformation [START_REF] Talaia | Receptor-like role for PQLC2 amino acid transporter in the lysosomal sensing of cationic amino acids[END_REF]. Further studies should tell whether this interaction is modulated by the lysosomal potential and by Arg, rather than Lys and His, as our model predicts.

Another feature of our model deserving experimental exploration is the prediction that the CSW recruitment cycle is nested within the mTORC1 cycle: the CSW complex would be recruited to lysosomes in response to a signal (lysosomal depolarization) induced by mTORC1 inactivation while it would eventually be released from lysosomes by cytosolic Arg before mTORC1 reactivates. The bidirectionality of PQLC2 could strengthen this temporal relationship between the CSW and mTORC1 cycles: when lysosomes freed from the CSW complex are still depolarized, PQLC2 reversal and lysosomal Arg import could help reactivating mTORC1 by increasing luminal Arg levels to upregulate the luminal Arg sensor SNAT9.

Materials and Methods

Solutions and reagents. Oocyte recordings were performed in ND100 medium (100 mM NaCl; 2 mM KCl; 1 mM MgCl2; 1.8 mM CaCl2) buffered with 5 mM MES-NaOH to pH 5.00, unless stated otherwise. L-Arg, L-Lys or L-His (Sigma-Aldrich) were added as monohydrochloride salts. For substrate-free solutions, the amino acid was replaced by N-methyl-D-glucamine (NMDG) hydrochloride (Sigma-Aldrich) to keep chloride concentration and osmolarity unchanged. The maximum concentration of NMDG used (20 mM) had no effect on PQCL2 and endogenous currents. Expression in Xenopus oocytes. Care and use of animals were performed in according to local and national guidelines (APAFIS agreement # 14316) in compliance with the European Animal Welfare regulations and home office regulations (UK). Xenopus laevis oocytes were prepared as described [START_REF] Ruivo | Mechanism of proton/substrate coupling in the heptahelical lysosomal transporter cystinosin[END_REF]. Defolliculated oocytes were injected with 50 ng of a cRNA (1 µg/µL) coding for an EGFP-tagged, sorting mutant of PQLC2 (PQLC2-LL290/291AA-EGFP) to express the transporter at the plasma membrane [START_REF] Jézégou | Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy[END_REF]. 24 to 48 h after injection, PQLC2-expressing oocytes were selected under an Eclipse TE-2000 epifluorescence microscope (Nikon) or an Axiophot epifluorescence microscope (Zeiss). Oocytes injected with 50 nL of water were used as negative control.

Two-electrode voltage clamp (TEVC) recording in Xenopus oocytes. Recordings were done at room temperature with two borosilicate-glass Ag/AgCl microelectrodes filled with 3 M KCl (0.5-3 MΩ tip resistance) connected to an O725C amplifier (Warner Instrument) and a Digidata 1440A interface controlled via pCLAMP 10.7 software (Molecular Devices). Oocytes were pre-incubated ≥ 30 min in ND100 pH 5.00 to activate PQLC2 [START_REF] Jézégou | Heptahelical protein PQLC2 is a lysosomal cationic amino acid exporter underlying the action of cysteamine in cystinosis therapy[END_REF] and lower their CAA contents by PQLC2 reversal. An Ag/AgCl reference electrode was positioned near the oocyte. When different chloride concentrations were used, the Ag/AgCl electrode was separated from the perfusion chamber using a salt bridge filled with 1.5 M KCl and 2 % agaragar. In low chloride conditions (Fig. 2E), a + 6 mV correction was applied to Vrev to compensate for the liquid junction potential at the tip of the salt bridge. Currents recorded at constant voltage were filtered using a 10-Hz low-pass filter and sampled at 1 kHz. For voltage jump experiments, currents were filtered at 0.5-kHz and sampled at 5 kHz. Voltage steps were applied from +100 mV to -100 mV with -20 mV decrements. To minimize the endogenous depolarization-induced conductance, oocytes were held at -20 mV and the holding potential was set to -40 mV for 100 ms just before and after each step. Data were analyzed with Clampfit 10.7 (Molecular Devices). Charge-substrate ratio, reversal potential and pHin measurements are described in SI Appendix, Supplementary Methods. Kinetic modeling. PQLC2 kinetics was modeled using a 6-state model (SI Appendix, Fig. S4A). Voltage dependence was implemented according to Läuger and Rauch [START_REF] Läuger | Microscopic description of voltage effects on ion-driven cotransport systems[END_REF], with symmetrical energy barriers unless stated otherwise (see rate constant equations detailed in SI Appendix, Supplementary Methods). Numerical values used in the simulations are provided in SI Appendix, Table S1. Briefly, substrate affinities were set in the millimolar range with an association limited by diffusion. Gating rate constants were in the millisecond time range, with faster kinetics in apo-than loaded-state transitions to account for the limited exchange activity of PQLC2 (Fig. 5). Voltage-dependence parameters were defined after a preliminary systematic study of their impact on I-V curves (SI Appendix, Fig. S4B). A total charge ( + ) displaced close -0.5 during apo state transitions proved critical to recapitulate the monotonic aspect of PQLC2 I-V curves. Indeed, this value allows the membrane potential to drive both the apo and loaded arms of the transport cycle, avoiding the emergence of a rate-limiting step over a large voltage range.

Steady-state currents, cycling frequencies and single-transporter trajectories were simulated with the MarkovEditor software (https://github.com/mikpusch/MarkovEditor). To detect exchange cycles, we duplicated the loaded arm of the model and divided by two the rate constant of split transitions (SI Appendix, Fig. S4F). Exchange is displayed by selecting the largest 8-state loop in the 'select cycle' function of MarkovEditor: the plot provides half the exchange rate as a function of voltage while each 6-state loop provides half the uniport rate. For reservoir filling, we used 5 × 10 8 transporters with a cytosolic volume of 1 µL and divided rate constants by a scaling factor (5000) to speed up simulations. Single-transporter stochastic simulations were repeated 5 times for 200 ms for each condition. To avoid sampling issues, the full sequences of states over time were recovered and transferred into Excel. A macro was used to detect each IN ↔ IN:S equilibrium event (cytosol-facing conformation) and determine their dwell time.

Statistical analysis.

A two-tailed Mann-Whitney test was used for comparison between two groups, and a one-way ANOVA with Tukey post hoc test for multiple groups. Error bars represent SEM.

See SI Appendix, Supplementary Methods for other techniques. (A) Systematic survey of substrate-specific parameters in a kinetic model of electrogenic uniporter. Gating constants of the loaded transporter (lower arm of the 6-state scheme) were systematically varied in a binary manner. The substrate luminal affinity (KD.out) was adjusted accordingly to meet the microscopic reversibility principle. I-V curves were simulated for the 16 resulting substrates at 20 and 5 mM luminal and cytosolic concentrations, respectively. The heat map shows the intensity of the outward current at +100 mV and the decrease of the inward current by the inner substrate at -50 mV. Substrates 3 and 11 were selected to mimic the Lys-like and Arg-like behaviors, respectively. (B) I-V curves of the S3 and S11 currents in a refined uniporter model for the indicated conditions. (C) Uniport and exchange cycling frequencies underlying the currents in B are shown at -50 mV and +100 mV. (D) The model was tested in simulations of a finite reservoir (1 µL) at -50 mV with 5 × 10 8 (E) Representative-single transporter trajectories with S11 corresponding to the times zero (left plot) and 270 s (right plot) in the reservoir filling simulations.

  For patch-clamp recordings in HEK293T cells, the substrate-free external solution contained: 130 mM NaCl; 5 mM KCl; 2 mM CaCl2; mM MgCl2; 20 mM glucose; 20 mM NMDG-Cl and 20 mM MES adjusted to pH 5.00 with NaOH or HCl (osmolarity: 315-330 mOsm). For substrate application, NMDG was replaced by 20 mM Lys, Arg or His. The micropipette solution contained: 130 mM CsCl; 10 mM EGTA; 2 mM CaCl2; 2 mM MgCl2; 10 mM Hepes adjusted to pH 7.35 -7.40 with KOH or HCl, supplemented with 20 mM NMDG, Arg or Lys (osmolarity: 295-305 mOsm). L-[2,3,4-3 H]arginine monhydrochloride (specific activity: 40-50 Ci/mmol) was from Perkin-Elmer.

Fig 1 :

 1 Fig 1: PQLC2 is not driven by protons. (A) Charge-substrate ratio measurements. Representative current traces elicited by [ 3 H]Arg in a PQLC2 oocyte and a negative control. The accumulated charge (shaded area) is proportional to accumulated Arg with a slope of 0.94 elementary charge per molecule. (B,C) Intracellular pH measurements with an ion-selective electrode (ISE). His (arrows), but not Arg or Lys, applied to PQLC2 oocytes at pH 5.0 induce an intracellular acidification. The graph in C shows a representative example of the acidification/current relationship. (D) Model for the His-induced acidification.

Fig 2 :

 2 Fig 2: PQLC2 is a cationic amino acid uniporter. (A) Protocol used for reversal potential measurements. After accumulating Lys through PQLC2, the oocyte is equilibrated with varying Lysout concentrations and subjected to voltage jumps. (B) Representative Lys-evoked current traces, obtained by subtracting the raw currents recorded at the numbered tick marks on the time's arrow in A. (C) Lysout dependence of Vrev for the oocyte shown in B (blue dots) and 5 other PQLC2 oocytes. Vrev is proportional to log([Lys]out) with a mean slope 52 ± 2 mV/decade, consistent with the translocation of 1 elementary charge per Lys molecule. The internal Lys concentration is deduced from this relationship (red dotted line). The value of Vrev at the end of the Lys loading phase (open purple dot) shows that a constant [Lys]in was maintained throughout the experiment. (D) Vrev measurements obtained with Arg as substrate. (E) Vrev is not affected by 10-to 100-fold changes in the external concentrations of H + , Na + , K + and Cl -.

Fig 3 :

 3 Fig 3: Argout inwardly rectifies the PQLC2 current. (A-D) Voltage dependence of the Lys and Arg currents. Naive PQLC2 oocytes were perfused twice with either 20 mM Lys or 20 mM Arg and subjected to voltage jumps every 20 s. Representative PQLC2 current traces in A and B were obtained by subtracting the raw current recorded at the corresponding tick marks on the time's arrow. With Arg, the outward current observed during the wash steps (3-1 subtraction) is fully suppressed by the presence of Arg in the bath (2-1 and 4-1 subtractions). C and D show the corresponding I-V curves during substrate application. In each panel, two subtraction procedures are compared. The left graph shows the result of the classical subtraction procedure, which induces an artefact during the second application of Arg (double arrow), reflecting the suppression of the outward current by Argout. The right graph shows the actual PQLC2 current. (E) Oocytes were perfused 5 min with 20 mM Lys and their Lys content was measured by LC-MS/MS. **, P ≤ 0.002. (F,G) I-V curves of the PQLC2 current recorded during the wash steps of the oocytes shown in A and B. The outward current reflects the efflux of accumulated Lys or Arg molecules. Its shift to an inward current at negative potential may reflect the reentry of Lys or Arg molecules leaving the oocyte at holding potential. (H) Mean I-V curves of 4 oocytes successively perfused with 20 mM Lys, Arg and Lys again. (I) Whole-cell patch clamp recording of PQLC2 in HEK cells. The mean current ± SEM (grey shading) evoked by 20 mM CAAout is plotted against voltage. CAAin (20 mM) was delivered, or not (20 mM NMDG), through the patch-clamp pipette. In CAA-loaded cells, the actual PQLC2 current cannot be determined owing to the lack of zero-in, zero-out reference. The dashed line shows its expected zero value based on the null reversal potential in symmetrical conditions. The double arrows reflect the suppression of PQLC2 outward current by extracellular Arg.

Fig 4 :

 4 Fig 4: Argin selectively reduces the inward current. Naive PQLC2 oocytes were perfused with a brief pulse of 20 mM Lys before and after sustained loading with 20 mM Lys or Arg at -60 mV. (A) Representative current traces. (B) Internal amino acid levels determined from the time integral of the loading currents based on an oocyte volume of 0.5 µL. (C) Ratio between the two pulse currents. (D) Current decrease during the loading step (arrows in A). The colored dots correspond to the oocytes shown in A. **, P < 0.01.

Fig 5 :

 5 Fig 5: Arginine trans-inhibits PQLC2. (A) Potential mechanisms for the Arg effect. The exchange and transinhibition mechanisms differentially alter the charge-substrate ratio (Q/S) of the transport cycle. (B) Charge-substrate ratio measurements in PQLC2 oocytes pre-loaded, or not, for ≥ 8 min at -60 mV with 20 mM Lys or Arg. Representative traces and mean ratio values for 6 to 11 oocytes per condition. *, P = 0.025; P ≤ 0.001; ****, P ≤ 10 -5 . (C) The charge-substrate ratio is plotted against the PQLC2 current decrease during the loading step. (D) PQLC2 oocytes perfused with a brief pulse of His before and after sustained loading with either Lys or Arg were recorded with an intracellular pH-selective electrode under voltage clamp. Representative current (top) and pH electrode (bottom) traces. The green dotted lines highlight the decreased acidification rate after Arg loading. (E) Relationship between the His-evoked acidification before and after Lys or Arg loading. Results are compared to those of PQLC2 oocytes without intervening loading steps (black squares).

Fig 6 :

 6 Fig 6: Modulation of the transporter cytosolic gate by the bound substrate recapitulates the Arg-specific properties.(A) Systematic survey of substrate-specific parameters in a kinetic model of electrogenic uniporter. Gating constants of the loaded transporter (lower arm of the 6-state scheme) were systematically varied in a binary manner. The substrate luminal affinity (KD.out) was adjusted accordingly to meet the microscopic reversibility principle. I-V curves were simulated for the 16 resulting substrates at 20 and 5 mM luminal and cytosolic concentrations, respectively. The heat map shows the intensity of the outward current at +100 mV and the decrease of the inward current by the inner substrate at -50 mV. Substrates 3 and 11 were selected to mimic the Lys-like and Arg-like behaviors, respectively. (B) I-V curves of the S3 and S11 currents in a refined uniporter model for the indicated conditions. (C) Uniport and exchange cycling frequencies underlying the currents in B are shown at -50 mV and +100 mV. (D) The model was tested in simulations of a finite reservoir (1 µL) at -50 mV with 5 × 10 8 (E) Representative-single transporter trajectories with S11 corresponding to the times zero (left plot) and 270 s (right plot) in the reservoir filling simulations.

Fig 7 :

 7 Fig 7: Lysosomal depolarization and the Arg-like substrate S11 antagonistically control the cytosol-facing conformation. (A) Kinetic differences induced by substrates 3 and 11 in the uniporter model. (B) The voltage dependence of the dwell time in cytosol-facing conformation was determined from singletransporter simulations in conditions mimicking nutrient replete and starved conditions (cytosolic substrate at 1 and 0.1 mM, respectively). Mean ± SEM of five 200-ms simulations, representing 100 to 750 events per condition. (C) Single-transporter simulations were repeated for a uniporter with an asymmetrical energy barrier of the cytosolic gate and otherwise identical model parameters. Dwell time distributions at two potentials and voltage dependence of the mean dwell time in cytosol-facing conformation (60 to 700 events per condition). (D) Putative model for the regulation of the interaction

[

  Fig 5

Acknowledgments

We thank Philippe Ascher and the late JacSue Kehoe for helpful advice. We thank the animal facility and the prototyping facility of UMS BioMedTech facilities at Université de Paris (CNRS UMS2009, Inserm US36) for housing the frogs and for making a microelectrode rack. This work was supported by the Cystinosis Research Foundation (grants n° CRFS-2014-004 and CRFF-2016-005 to BG) and by the French Agence Nationale de la Recherche (grant n° ANR-18-CE11-0009-01 to BG).